Furthermore, we previously observed that oral SAK3 administration potently ameliorated ischemia-induced cognitive impairments and neuronal death by stimulating nAChR-regulated ACh release in the hippocampus of the mouse brain [54]. This evidence concerns the gene CHRNA4 and ischemia.